The best Bull and Bear pitches based on recency and number of recommendations.
Has a solid pipeline of products that should be advancing into phase 3 stage of FDA approval and beyond through the next 12 to 36 months. Most notable of all its products currently in phase 2 stage of development, is the drug Convivia. It is the only… More
36 month data from the CYST-HD trial of DR Cysteamine for Huntington's Disease is due to drop this month and I'm not optimistic. First of all, the rationale for the trial is sketchy - induction of beneficial cellular stress responses via the… More
Read the most recent pitches from players about RPTP.DL.
Find the members with the highest scoring picks in RPTP.DL.
See what the Wall Street professionals think, according to their public statements and filings.